McNeil, the Johnson & Johnson subsidiary that makes children’s Tylenol, plead guilty today in Philadelphia Federal Court to criminal charges of faulty manufacturing practices and agreed to pay $25 million in fines.

McNeil agreed to pay $20 million in criminal fines and a $5 million criminal forfeiture to settle a misdemeanor charge alleging violations of the Federal Food, Drug, and Cosmetic Act. The charges stated that the company was responsible for knowingly keeping contaminated drugs on store shelves when they failed to correct issues regarding a distribution of bottles of Children’s Tylenol that contained metallic pieces. A consumer brought the issue to McNeil’s attention but the situation was not remedied.

The settlement comes just a few weeks after another Johnson & Johnson subsidiary, Janssen Pharmaceuticals, was slapped with a $2.5M jury verdict in Philadelphia for failure to warn on behalf of a young boy who developed large breasts (gynecomastia) after taking Risperdal. Johnson & Johnson was also hit hard regarding Risperdal after they were forced to pay $136M of a $327M verdict in South Carolina for illegally marketing Risperdal to hyperactive children and the elderly.

More information regarding McNeil’s settlement of criminal charges was not yet available. Updates provided as they come.

New Jersey and Philadelphia Personal Injury Lawyers

The Philadelphia personal injury lawyers at Messa & Associates are experienced at handling cases involving pharmaceutical and drug product injuries. Our extremely skilled team of personal injury lawyers and medical experts is dedicated to ensuring you receive proper compensation for your personal injuries. If you have suffered an injury as a result of the use of Children’s Tylenol, Risperdal, a defective pharmaceutical drug product, or any other type of personal injury, contact the personal injury lawyers of Messa & Associates for a free consultation. Call toll free at 1-877-MessaLaw, or submit a free online inquiry.